148 related articles for article (PubMed ID: 34475934)
1. Effect of Intensity Modulated Radiotherapy (IMRT) on the immunity, physical status and clinical effect of locally advanced NSCLC patients.
Xu JK
Pak J Med Sci; 2021; 37(5):1480-1485. PubMed ID: 34475934
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
[TBL] [Abstract][Full Text] [Related]
3. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma.
Yang Q; Li G; Wu X; Lin H; Wu W; Xie X; Zhu Y; Cai W; Shi C; Zhuo S
Front Oncol; 2023; 13():1136366. PubMed ID: 37064142
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of Chemotherapy combined with Immunotherapy in patients with advanced NSCLC and the effect on their nutritional status and immune function.
Jiao J; Li WW; Shang YH; Li XF; Jiao M
Pak J Med Sci; 2023; 39(2):404-408. PubMed ID: 36950407
[TBL] [Abstract][Full Text] [Related]
7. Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
Chi A; Wen S; Monga M; Almubarak M; He X; Rojanasakul Y; Tse W; Remick SC
PLoS One; 2016; 11(9):e0162453. PubMed ID: 27611833
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of immunotherapy combined with chemotherapy in patients with advanced gastric cancer, its effect on nutritional status and Changes of peripheral blood T lymphocyte subsets.
Li WW; Jiao J; Wang ZY; Wei YN; Zhang YF
Pak J Med Sci; 2021; 37(7):1902-1907. PubMed ID: 34912415
[TBL] [Abstract][Full Text] [Related]
9. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
10. Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
Ye W; Song Z; Lin Z
Evid Based Complement Alternat Med; 2022; 2022():5067402. PubMed ID: 36193130
[TBL] [Abstract][Full Text] [Related]
11. Efficacy comparison between microwave ablation combined with radiation therapy and radiation therapy alone for locally advanced nonsmall-cell lung cancer.
Song P; Sun W; Pang M; He W; Zhang W; Sheng L
J Cancer Res Ther; 2021 Jul; 17(3):715-719. PubMed ID: 34269304
[TBL] [Abstract][Full Text] [Related]
12. Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma.
Zhang W; Yan C; Gao X; Li X; Cao F; Zhao G; Zhao J; Er P; Zhang T; Chen X; Wang Y; Jiang Y; Wang Q; Zhang B; Qian D; Wang J; Zhou D; Ren X; Yu Z; Zhao L; Yuan Z; Wang P; Pang Q
Oncologist; 2021 Jul; 26(7):e1110-e1124. PubMed ID: 33893689
[TBL] [Abstract][Full Text] [Related]
13. [Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy].
Wang JB; Jiang W; Ji Z; Cao JZ; Liu LP; Men Y; Xu C; Wang XZ; Hui ZG; Liang J; Lyu JM; Zhou ZM; Xiao ZF; Feng QF; Chen DF; Zhang HX; Yin WB; Wang LH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):607-14. PubMed ID: 27531481
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer.
Abe T; Iino M; Saito S; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Miura Y; Kaira K; Kagamu H; Noda SE; Kato S
J Radiat Res; 2021 Sep; 62(5):894-900. PubMed ID: 34260719
[TBL] [Abstract][Full Text] [Related]
15. The clinical effects of low-dose splenic irradiation combined with chest three-dimensional conformal radiotherapy on patients with locally advanced non-small-cell lung cancer: a randomized clinical trial.
Yu H; Qu Y; Shang Q; Yan C; Jiang P; Wang X; Liang D; Jiang T
Onco Targets Ther; 2016; 9():5545-52. PubMed ID: 27660472
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.
Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M
Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Camrelizumab in Advanced Non-Small-Cell Lung Cancer and Prognostic Analysis of Different PET/CT Features.
Zou J; Li C; Han Y; Xing Y; Zhan Y; Zuo C; Ren X; Xing R; Zhang N
J Oncol; 2022; 2022():9942918. PubMed ID: 35368889
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors.
Zhang X; Yang D; Jiang Y; Huang L; Wang C; Tao D; Liu X; Lei Y; Wu Y; Zhou W
J Inflamm Res; 2021; 14():4205-4215. PubMed ID: 34483676
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
20. [Effect of intensity modulated radiation therapy on oral mucosa and immune function in patients with nasopharyngeal carcinoma].
Liang S; Zhang N; Chen L; Zhang Y; Zheng Z; Luo W; Xu T; Lü Z; Li S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):505-510. PubMed ID: 29886466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
